US.ZTS · Zoetis

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.4,
      "details": {
        "atrPct": 2.25132765221687,
        "turnoverUsdM": 235.12190055,
        "liquidityPoints": 0.4,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.ZTS",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 77.3242,
      "strength_details": {
        "ma_score": 2,
        "atr_score": 2,
        "rsi_score": 0.5,
        "macd_score": 3,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.1,
      "stop_loss_percent": 4.5,
      "take_profit_price": 85.0185,
      "target_multiplier": 1.9,
      "technical_strength": 1.75,
      "take_profit_percent": 5
    },
    "positionPoints": 1.4,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 4.50265530443374,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 74.5,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 67.5,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 7
  },
  "market": {
    "ma20": 75.3695,
    "ma50": 74.7296,
    "close": 80.97,
    "prevClose": 81.03,
    "avgVolume20": 4071641,
    "volumeRatio": 0.71,
    "changePercent": -0.07
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 7,
    "details": {
      "ret_5d": 0.017338861666038374,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 7,
      "vcp_bonus": 0,
      "vol_ratio": 0.7044982556249424,
      "ret_points": 4,
      "vol_points": 0,
      "range_ratio": 0.578657316259096,
      "volat_points": 0,
      "day_range_pct": 0.013461800666913652,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 74.5,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 4.3,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 86,
        "contribution": 4.3
      },
      {
        "raw": 15.6,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 78,
        "contribution": 15.6
      },
      {
        "raw": 9.6,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 64,
        "contribution": 9.6
      },
      {
        "raw": 6,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 30,
        "contribution": 6
      },
      {
        "raw": 7.2,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 72,
        "contribution": 7.2
      },
      {
        "raw": 20.8,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 69.33,
        "contribution": 20.8
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "謹慎買入",
    "result": 67.5,
    "details": [
      "基本面分析總分: 4.3/5分",
      "資金流分析總分: 15.6/20分",
      "市場環境分析總分: 9.6/15分",
      "催化劑分析: 6/20分",
      "風險管理總分: 7.2/10分",
      "技術信號分析總分: 20.8/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 6,
      "基本面": 4.3,
      "資金流": 15.6,
      "市場環境": 9.6,
      "情緒分析": 4,
      "技術信號": 20.8,
      "風險管理": 7.2
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 1
            }
          },
          "catalystPoints": 6
        }
      },
      "基本面": {
        "max": 5,
        "grade": "優秀",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.5,
          "epsPoints": 0.4,
          "roePoints": 0.75,
          "debtPoints": 0.3,
          "marginPoints": 0.75,
          "turnoverUsdM": 235.12190055,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.4,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "良好",
        "items": {
          "cmfPoints": 2.4,
          "mfiPoints": 4,
          "obvPoints": 3.2,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.ZTS",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "一般",
        "items": {
          "vix": {
            "score": 1.8,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 19.45
            }
          },
          "trend": {
            "score": 0.8,
            "details": {
              "qqq": {
                "ma20": 734.0185023500001,
                "ma50": 725.4347994000001,
                "name": "QQQ",
                "close": 712.20001,
                "points": 0.4
              },
              "spy": {
                "ma20": 770.1384979000001,
                "ma50": 767.5889950999999,
                "name": "SPY",
                "close": 765.37,
                "points": 0.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.25132765221687,
          "atrPoints": 3,
          "cciPoints": 4,
          "vixPoints": 1.8,
          "marketTrendPoints": 0.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 3,
              "sentimentScoreRaw": 0.9
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 143137630,
                "url": "https://finnhub.io/api/news?id=e2abfc565ef0ec7098c826f24d9c6010d7d6d801e595759c0dd060964d751c1e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "In the latest trading session, Zoetis (ZTS) closed at $81.03, marking a -1.18% move from the previous day.",
                "category": "company",
                "datetime": 1792790103,
                "headline": "Zoetis (ZTS) Registers a Bigger Fall Than the Market: Important Facts to Note"
              },
              {
                "id": 143104276,
                "url": "https://finnhub.io/api/news?id=12dec2da51e73e3d58d1875772428842d2100dc7e0c4ca0a1127faa2465f0df9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Is IDXX a good stock to buy? We came across a bullish thesis on IDEXX Laboratories, Inc. on Astute Optics – US’s Substack. In this article, we will summarize the bulls’ thesis on IDXX. IDEXX Laboratories, Inc.’s share was trading at $553.48 as of October 21st 2026. IDXX’s trailing and forward P/E were 36.65 and 31.45 respectively […]",
                "category": "company",
                "datetime": 1792700301,
                "headline": "IDEXX Laboratories (IDXX) vs. ZTS and NEOG: Can Raised Guidance and Product Expansion Drive Further Earnings Growth?"
              },
              {
                "id": 143070305,
                "url": "https://finnhub.io/api/news?id=0dcca9defb40dbacb680fb15d34e9aa5021beaad62ed0d31c108abc878635846",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Zoetis offers diversification and stability, while ImmuCell boasts stronger sales growth and expansion potential.",
                "category": "company",
                "datetime": 1792593060,
                "headline": "ZTS vs. ICCC: Which Animal Health Stock Is the Better Investment Bet?"
              },
              {
                "id": 142920654,
                "url": "https://finnhub.io/api/news?id=7b67ef8eef3ec8d0698207f1552821b11e346ff48db38edfab6f14937b63c4b7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Middle Coast Investing, an investment advisor firm, released its second-quarter 2026 investor letter. The letter can be downloaded here. Market breadth in Q3 2026 reviews shows dominance by a few sectors, with S&P 500 stocks averaging a 9.7% return and only 40.55% above their 200-day moving average. Key themes include AI, inflation, and the U.S.-Iran conflict, […]",
                "category": "company",
                "datetime": 1792080245,
                "headline": "Zoetis (ZTS) Hit by Guidance Cuts, Met with Market Shrug"
              },
              {
                "id": 142916896,
                "url": "https://finnhub.io/api/news?id=193f58efb7ed97df6eb6972c2cfb7fd8e162838174894ec53408af76241f237e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Zoetis has gotten torched over the last six months - since April 2026, its stock price has dropped 37.6% to $75.34 per share. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.",
                "category": "company",
                "datetime": 1792071867,
                "headline": "3 Reasons ZTS is Risky and 1 Stock to Buy Instead"
              },
              {
                "id": 142880217,
                "url": "https://finnhub.io/api/news?id=47a3c5af87fff42cbf2c3fd786c9b2e35bfb402cdd1c726fb407d6b7543344ef",
                "image": "https://www.chartmill.com/images/uploads/thumbnail_article_luc_kroeze_c1f44c837d.webp",
                "source": "ChartMill",
                "related": "ZTS",
                "summary": "Zoetis quality investing analysis: high ROIC, strong cash flow, low debt, reasonable valuation, but revenue growth lags Caviar Cruise screen criteria.",
                "category": "company",
                "datetime": 1791976866,
                "headline": "Zoetis (NYSE:ZTS): A Quality Investing Case Study in Animal Health"
              },
              {
                "id": 142870466,
                "url": "https://finnhub.io/api/news?id=c9e9b9b51159e9087486cfd19062661cfc3d3276969620049c76c869b2c9acd8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Board appointment and dividend set the stage for Zoetis Zoetis (ZTS) has given investors fresh governance and income headlines in October, with Iris Knobloch joining the Board and a fourth quarter dividend of $0.53 per share affirmed. For context, Zoetis shares trade at US$74.30 after a 4.16% 7-day share price gain. However, the 1-year total shareholder return has declined 47.21% and the 5-year total shareholder return is down 61.56%, suggesting recent momentum is tentative against a weaker...",
                "category": "company",
                "datetime": 1791961777,
                "headline": "Zoetis (ZTS) Board Update And Dividend Keep Undervalued Narrative In Focus"
              },
              {
                "id": 142852685,
                "url": "https://finnhub.io/api/news?id=b4f73bc04760ed99ae425087ffdccb8743bd459bec8676a425e5ebcaa1a1ab25",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at branded pharmaceuticals stocks, starting with Zoetis (NYSE:ZTS).",
                "category": "company",
                "datetime": 1791908344,
                "headline": "Branded Pharmaceuticals Stocks Q2 In Review: Zoetis (NYSE:ZTS) Vs Peers"
              }
            ],
            "raw_source": [
              {
                "id": 143201697,
                "url": "https://finnhub.io/api/news?id=5a66f3c8a41c7c96ee898feddb2e9473753767632cd20bd6fe4813ae2519291f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "For questions about this article or underlying research, email help@trefis.com.",
                "category": "company",
                "datetime": 1793034972,
                "headline": "Can Zoetis Stock Jump 30%?"
              },
              {
                "id": 143143733,
                "url": "https://finnhub.io/api/news?id=1bf25eff3f4e92d5e3da84b6ae1d3b3cef34fe9794d5c4985be63bc283f867aa",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "Get a weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers, including dividend changes and key ex-dividend dates.",
                "category": "company",
                "datetime": 1792793778,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week October 25"
              },
              {
                "id": 143137630,
                "url": "https://finnhub.io/api/news?id=e2abfc565ef0ec7098c826f24d9c6010d7d6d801e595759c0dd060964d751c1e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "In the latest trading session, Zoetis (ZTS) closed at $81.03, marking a -1.18% move from the previous day.",
                "category": "company",
                "datetime": 1792790103,
                "headline": "Zoetis (ZTS) Registers a Bigger Fall Than the Market: Important Facts to Note"
              },
              {
                "id": 143104276,
                "url": "https://finnhub.io/api/news?id=12dec2da51e73e3d58d1875772428842d2100dc7e0c4ca0a1127faa2465f0df9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Is IDXX a good stock to buy? We came across a bullish thesis on IDEXX Laboratories, Inc. on Astute Optics – US’s Substack. In this article, we will summarize the bulls’ thesis on IDXX. IDEXX Laboratories, Inc.’s share was trading at $553.48 as of October 21st 2026. IDXX’s trailing and forward P/E were 36.65 and 31.45 respectively […]",
                "category": "company",
                "datetime": 1792700301,
                "headline": "IDEXX Laboratories (IDXX) vs. ZTS and NEOG: Can Raised Guidance and Product Expansion Drive Further Earnings Growth?"
              },
              {
                "id": 143078183,
                "url": "https://finnhub.io/api/news?id=cc9bf5aab1152f8234329b7d6bdc8eb1927731b98d294b46d37df65a0fc610ad",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "For questions about this article or underlying research, email help@trefis.com.",
                "category": "company",
                "datetime": 1792640090,
                "headline": "How Unusual Is Zoetis's Latest Sales Growth?"
              },
              {
                "id": 143076665,
                "url": "https://finnhub.io/api/news?id=039ece311b2c8f2cb63abfd53bafea68e72dfa3fd4df5cb6ea2ab89ef021790b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Three ETFs all claim to own quality businesses, yet only four companies appear in all three portfolios. The definition of quality turns out to matter enormously for what ends up in your account.",
                "category": "company",
                "datetime": 1792630984,
                "headline": "SPHQ, QUAL, and MOAT Define Quality Differently. Those Rules Decide What You Own"
              },
              {
                "id": 143070305,
                "url": "https://finnhub.io/api/news?id=0dcca9defb40dbacb680fb15d34e9aa5021beaad62ed0d31c108abc878635846",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Zoetis offers diversification and stability, while ImmuCell boasts stronger sales growth and expansion potential.",
                "category": "company",
                "datetime": 1792593060,
                "headline": "ZTS vs. ICCC: Which Animal Health Stock Is the Better Investment Bet?"
              },
              {
                "id": 143031815,
                "url": "https://finnhub.io/api/news?id=0fd1e70c60074b521420666410d81e6607e9d5b754914a886d52f0c680c029a5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "PARSIPPANY, N.J., October 20, 2026--Convenia RTU for Dogs provides up to 14 days of antibiotic treatment in a single dose for susceptible bacterial skin infections",
                "category": "company",
                "datetime": 1792528920,
                "headline": "Zoetis Receives FDA Approval for Convenia® RTU for Dogs (cefovecin injectable suspension), Helping More Medium and Large Dogs Access Single-Injection Treatment"
              },
              {
                "id": 143031925,
                "url": "https://finnhub.io/api/news?id=1c8e4d8fb875d44021fbfe8b9ccac9f0bbceb42075708d6aeb607d5511862993",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2180557660/image_2180557660.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "Zoetis (ZTS) rated sell as growth slows and guidance falls. Read the latest analysis on the stock here.",
                "category": "company",
                "datetime": 1792516944,
                "headline": "Zoetis: Weakening Fundamentals Overshadow The Discount"
              },
              {
                "id": 143025167,
                "url": "https://finnhub.io/api/news?id=4bfb8d37828d880b69512fa556a6e88025420ce344389cf75c07778d1668b3de",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Apple downgraded, Akamai upgraded: Wall Street's top analyst calls",
                "category": "company",
                "datetime": 1792503315,
                "headline": "Apple downgraded, Akamai upgraded: Wall Street's top analyst calls"
              },
              {
                "id": 143026299,
                "url": "https://finnhub.io/api/news?id=047a8f7b40a7ad7ea4826c6ad830d435d35a328225cc31a852577bb1e91bb2c2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Investing.com -- Jefferies downgraded Zoetis and Elanco to Hold from Buy on Tuesday, warning that pricing power in animal health is at risk. The firm reiterated its Buy rating on IDEXX Laboratories.",
                "category": "company",
                "datetime": 1792501571,
                "headline": "Jefferies downgrades Zoetis, Elanco on pricing risk; prefers IDEXX"
              },
              {
                "id": 143022225,
                "url": "https://finnhub.io/api/news?id=2cc7648c72c62fa7256c9fbc3b0d5751d2543999f3305473540e1577e4f158c0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Pre-Market Stock Futures: Futures are mixed, but Nasdaq futures are lower as chipmakers come under attack this morning. The AI trade made a Monday comeback after a dreadful period last week. The Goldman Sachs (NYSE: GS) upgrade of CoreWeave (NASDAQ: CRWV) was a lynchpin in Monday’s move higher, despite the shares actually closing flat on the […]",
                "category": "company",
                "datetime": 1792497473,
                "headline": "Here Are Tuesday’s Top Wall Street Analyst Research Calls: Akamai Technolgies, Apple, Blackrock, Ford Motor, Healthcare Realty Trust, Noble, Sunoco LP, Venture Global, Western Midstream Partners, Zoetis, and More"
              },
              {
                "id": 143028035,
                "url": "https://finnhub.io/api/news?id=5b0c61fdbc4250c630e45a88832841101c8a5212515dfc77a040cec010a53c5a",
                "image": "",
                "source": "Benzinga",
                "related": "ZTS",
                "summary": "https://www.fda.gov/animal-veterinary/cvm-updates/fda-approves-ready-use-cefovecin-injectable-treatment-certain-skin-infections-dogs",
                "category": "company",
                "datetime": 1792490999,
                "headline": "FDA Approves Ready-To-Use Cefovecin Injectable For Treatment Of Certain Skin Infections In Dogs"
              },
              {
                "id": 143025038,
                "url": "https://finnhub.io/api/news?id=9df19a92ed5225c2d2520bf1aebe36be86c2affd9111f135926648a2fcf3b683",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/20/Ljubljana--Slovenia---2022-September-18-.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ZTS",
                "summary": "Analysts downgraded Werner, Zoetis, Apple, Heartland Express and Elanco, cutting ratings to Neutral/Hold and lowering price targets.",
                "category": "company",
                "datetime": 1792484524,
                "headline": "This Apple Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday"
              },
              {
                "id": 143028037,
                "url": "https://finnhub.io/api/news?id=0a9489b77c45458d7d6f38479f778166f3fca19744585c3e29e184253bc321cc",
                "image": "",
                "source": "Benzinga",
                "related": "ZTS",
                "summary": "Jefferies  analyst Keith Devas   downgrades Zoetis (NYSE:ZTS) from Buy to Hold and lowers the price target from $103 to $83.",
                "category": "company",
                "datetime": 1792483762,
                "headline": "Jefferies Downgrades Zoetis to Hold, Lowers Price Target to $83"
              },
              {
                "id": 142948198,
                "url": "https://finnhub.io/api/news?id=658776dbc7db6b617f3e22e4e3348b5d99b3e27275037865fa08ee28d1c6ba71",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "The investment case for Zoetis Inc. (NYSE:ZTS) has changed significantly since declining demand in its U.S. companion-animal business has put pressure on earnings forecasts and affected the price of its shares. As a company in the animal health sector, Zoetis produces medicines, vaccines, and diagnostic products for both pets and livestock, and the wide range […]",
                "category": "company",
                "datetime": 1792164586,
                "headline": "Zoetis’ Valuation Has Fallen Sharply, but Has the Market Overreacted?"
              },
              {
                "id": 142945208,
                "url": "https://finnhub.io/api/news?id=bcf6b59db861e57d5b261ac684ed28930b794780ff8583ca87806e8e3c6f80ee",
                "image": "",
                "source": "Benzinga",
                "related": "ZTS",
                "summary": "Goldman Sachs  analyst Matt Dellatorre   initiates coverage on Zoetis (NYSE:ZTS) with a Neutral rating and announces Price Target of $74.",
                "category": "company",
                "datetime": 1792129137,
                "headline": "Goldman Sachs Initiates Coverage On Zoetis with Neutral Rating, Announces Price Target of $74"
              },
              {
                "id": 142920654,
                "url": "https://finnhub.io/api/news?id=7b67ef8eef3ec8d0698207f1552821b11e346ff48db38edfab6f14937b63c4b7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Middle Coast Investing, an investment advisor firm, released its second-quarter 2026 investor letter. The letter can be downloaded here. Market breadth in Q3 2026 reviews shows dominance by a few sectors, with S&P 500 stocks averaging a 9.7% return and only 40.55% above their 200-day moving average. Key themes include AI, inflation, and the U.S.-Iran conflict, […]",
                "category": "company",
                "datetime": 1792080245,
                "headline": "Zoetis (ZTS) Hit by Guidance Cuts, Met with Market Shrug"
              },
              {
                "id": 142916896,
                "url": "https://finnhub.io/api/news?id=193f58efb7ed97df6eb6972c2cfb7fd8e162838174894ec53408af76241f237e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Zoetis has gotten torched over the last six months - since April 2026, its stock price has dropped 37.6% to $75.34 per share. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.",
                "category": "company",
                "datetime": 1792071867,
                "headline": "3 Reasons ZTS is Risky and 1 Stock to Buy Instead"
              },
              {
                "id": 142880217,
                "url": "https://finnhub.io/api/news?id=47a3c5af87fff42cbf2c3fd786c9b2e35bfb402cdd1c726fb407d6b7543344ef",
                "image": "https://www.chartmill.com/images/uploads/thumbnail_article_luc_kroeze_c1f44c837d.webp",
                "source": "ChartMill",
                "related": "ZTS",
                "summary": "Zoetis quality investing analysis: high ROIC, strong cash flow, low debt, reasonable valuation, but revenue growth lags Caviar Cruise screen criteria.",
                "category": "company",
                "datetime": 1791976866,
                "headline": "Zoetis (NYSE:ZTS): A Quality Investing Case Study in Animal Health"
              },
              {
                "id": 142870466,
                "url": "https://finnhub.io/api/news?id=c9e9b9b51159e9087486cfd19062661cfc3d3276969620049c76c869b2c9acd8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Board appointment and dividend set the stage for Zoetis Zoetis (ZTS) has given investors fresh governance and income headlines in October, with Iris Knobloch joining the Board and a fourth quarter dividend of $0.53 per share affirmed. For context, Zoetis shares trade at US$74.30 after a 4.16% 7-day share price gain. However, the 1-year total shareholder return has declined 47.21% and the 5-year total shareholder return is down 61.56%, suggesting recent momentum is tentative against a weaker...",
                "category": "company",
                "datetime": 1791961777,
                "headline": "Zoetis (ZTS) Board Update And Dividend Keep Undervalued Narrative In Focus"
              },
              {
                "id": 142852685,
                "url": "https://finnhub.io/api/news?id=b4f73bc04760ed99ae425087ffdccb8743bd459bec8676a425e5ebcaa1a1ab25",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at branded pharmaceuticals stocks, starting with Zoetis (NYSE:ZTS).",
                "category": "company",
                "datetime": 1791908344,
                "headline": "Branded Pharmaceuticals Stocks Q2 In Review: Zoetis (NYSE:ZTS) Vs Peers"
              },
              {
                "id": 142847665,
                "url": "https://finnhub.io/api/news?id=22036da91f6405ab60c990d7250a0fdacf2ec6d0382b00144f92ac4554a519ad",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "PARSIPPANY, N.J., October 13, 2026--Zoetis Inc. (NYSE:ZTS) today announced the appointment of Iris Knobloch to its Board of Directors, effective as of December 1, 2026. With decades of experience across global media and consumer businesses, Ms. Knobloch brings a distinct combination of international leadership, proven public company board experience across financial services, hospitality and media, and deep consumer and digital expertise to the Zoetis Board. She currently serves on the boards of",
                "category": "company",
                "datetime": 1791891000,
                "headline": "Zoetis Appoints Iris Knobloch to its Board of Directors"
              },
              {
                "id": 142810765,
                "url": "https://finnhub.io/api/news?id=bd140ab014b5cf6f3e5ea4c4f50b6f6f01dd0f80f065768a70c0742a397f6f2a",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/688741730/image_688741730.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "An equally weighted portfolio of the top 10 stocks yields 2.8% but would have underperformed SPY over the past 5 years. Check out dividend growth stocks here.",
                "category": "company",
                "datetime": 1791758522,
                "headline": "10 Dividend Growth Stocks: October 2026"
              },
              {
                "id": 142806662,
                "url": "https://finnhub.io/api/news?id=88a74baf83fffd8b419bb6c42be37ea4daa59b2aa69282ceb6e60f787cf3393b",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2252678669/image_2252678669.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "Track 50 top dividend growth stocks: AMAT, DHI & HD climb as valuations shift.",
                "category": "company",
                "datetime": 1791722816,
                "headline": "Top 50 High-Quality Dividend Growth Stocks For October 2026"
              },
              {
                "id": 142805719,
                "url": "https://finnhub.io/api/news?id=d1ed17e76605d3bb1bc4f052951377f7b02e1277c0d41ff40c22be2f7dbd30ce",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Zoetis has seen its share price under pressure in recent years, even with a short-term bounce. This puts fresh attention on whether the current valuation is still supported by its earnings power. With the animal health group in the spotlight after mixed business updates, the key issue for you as an investor is what today's earnings actually justify. Over the past 5 years, Zoetis shareholders have seen the stock fall 60.9%, which makes the current price level a live question rather than a...",
                "category": "company",
                "datetime": 1791720702,
                "headline": "Zoetis (ZTS) Stock May Trade At A Discount As Q2 Pressure Persists"
              },
              {
                "id": 142768145,
                "url": "https://finnhub.io/api/news?id=65831ba99049f7d1895ce78c619d1859917817b1e920d945eff4668248b0f4fe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "In the most recent trading session, Zoetis (ZTS) closed at $74.81, indicating a +2.37% shift from the previous trading day.",
                "category": "company",
                "datetime": 1791580505,
                "headline": "Zoetis (ZTS) Outpaces Stock Market Gains: What You Should Know"
              },
              {
                "id": 142767072,
                "url": "https://finnhub.io/api/news?id=3d2ed8994bf06290bae931b73a6a13db796ca6fce85a100a435a5bc0dcd6e13f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Whether you want a higher 3% dividend yield or a quickly growing dividend that yields 1.2%, these two stocks look like rare opportunities.",
                "category": "company",
                "datetime": 1791576300,
                "headline": "A Once-in-a-Decade Opportunity: 2 Magnificent Dividend Stocks Down 34% to 52% I'm Buying Right Now"
              },
              {
                "id": 142791211,
                "url": "https://finnhub.io/api/news?id=8515c8cafa622c1ba55b6a4727cf33da0134590c035e2163865fea16ff57ffd7",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ZTS",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders will",
                "category": "company",
                "datetime": 1791552910,
                "headline": "10 Health Care Stocks Whale Activity In Today’s Session"
              },
              {
                "id": 142754007,
                "url": "https://finnhub.io/api/news?id=4baa07edb0173cb3c6df8828e8bb1501f402c4c9b2b857651a7bc282ce58221e",
                "image": "https://www.chartmill.com/images/uploads/Best_Dividend_500_264px_webp_9524a3945f.webp",
                "source": "ChartMill",
                "related": "ZTS",
                "summary": "Zoetis is a dividend stock with strong profitability, low payout ratio, and 20.56% dividend growth, but slower earnings remain a risk.",
                "category": "company",
                "datetime": 1791538836,
                "headline": "Zoetis (NYSE:ZTS): A Quality Dividend Stock for Income Investors With Room to Grow"
              },
              {
                "id": 142733312,
                "url": "https://finnhub.io/api/news?id=85cbdaa0f9a83fa20249dead4b6503d31276c12c50796b88623a9c572c26e86b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "PARSIPPANY, N.J., October 08, 2026--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.53 per share for the fourth quarter of 2026. The dividend will be paid on Tuesday, December 1, 2026, to all holders of record of the Company’s common stock as of the close of business on Friday, October 30, 2026.",
                "category": "company",
                "datetime": 1791490500,
                "headline": "Zoetis Declares Fourth Quarter 2026 Dividend"
              },
              {
                "id": 142732290,
                "url": "https://finnhub.io/api/news?id=22be5015ff8334f3bfeb497148b5c9b03f33028d27c8887e271efa1669d2fced",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Zoetis (NYSE:ZTS) reported new peer-reviewed data on its Simparica Trio product comparing protection against resistant heartworm to NexGard Plus. The publication focuses on a resistant heartworm strain that has become a growing concern for veterinarians and dog owners. Researchers found Simparica Trio provided stronger protection against the resistant heartworm strain than competitor NexGard Plus in the study. Stronger protection by Simparica Trio against resistant heartworm only tells part...",
                "category": "company",
                "datetime": 1791482919,
                "headline": "Zoetis (ZTS) Says Study Shows Simparica Trio Outperformed A Rival On Resistant Heartworm"
              },
              {
                "id": 142731108,
                "url": "https://finnhub.io/api/news?id=664d09db37b68e5267609d3b907b91d63226bf384f6ab20679365506df8e3365",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "PAHC's Animal Health gains from MFA, vaccine and mineral nutrition growth, but tariffs, costs and currency swings remain key risks to its outlook.",
                "category": "company",
                "datetime": 1791476520,
                "headline": "Is it the Right Time to Add Phibro Stock to Your Portfolio?"
              },
              {
                "id": 142728425,
                "url": "https://finnhub.io/api/news?id=1f6b2e084f37767081588e49aa339e50321e0e63b9c9e2a1f99a82ceda8cdbbd",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2291417043/image_2291417043.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "Neogen Corporation's products are used for detecting contamination, checking quality, and protecting livestock. Read more on NEOG stock here.",
                "category": "company",
                "datetime": 1791454968,
                "headline": "Neogen Corporation: Promising Recurring Demand With Food Safety"
              },
              {
                "id": 142698563,
                "url": "https://finnhub.io/api/news?id=c6e0ab0cf952b1b3147ea613e6a5b07cb02af2f0738298ab0bdc24fb3f8ef01a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "It's going to be a very long road back to all-time highs for some well-known companies.",
                "category": "company",
                "datetime": 1791389750,
                "headline": "These 7 major S&P 500 stocks need to rally at least 200% to reclaim their peaks"
              },
              {
                "id": 142695147,
                "url": "https://finnhub.io/api/news?id=303b9019184f0fc4db851963052101f896b811e36a79ee7a385d3e7c2cfe2c44",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Key TakeawaysNeogen shares jumped 4% after fiscal first-quarter revenue of $222. 8 million beat the $208.",
                "category": "company",
                "datetime": 1791380059,
                "headline": "Neogen Soars 4% as Q1 Revenue Beat and Raised Guidance Show “Encouraging Progress”"
              },
              {
                "id": 142662157,
                "url": "https://finnhub.io/api/news?id=16b38a3c85b62af7442841b64d8f56b21564d23cd5f5c671461a613f8e313ef9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "PARSIPPANY, N.J., October 06, 2026--Drug-resistant heartworm is a growing concern for veterinarians and pet owners as resistant heartworm populations emerge. New research shows that not all heartworm preventives perform equally against these resistant isolates. Macrocyclic lactone (ML) resistance means some heartworm isolates are less sensitive to the drug class used in today’s heartworm disease preventives. As ML resistance continues to challenge heartworm prevention, veterinarians need data th",
                "category": "company",
                "datetime": 1791286200,
                "headline": "New Peer-Reviewed Publication on Laboratory Study That Demonstrated Simparica Trio® Protected 3x More Dogs From Infection With a Resistant Heartworm Isolate Than NexGard® Plus1"
              },
              {
                "id": 142662285,
                "url": "https://finnhub.io/api/news?id=7e1eb27d1f4ac3e3c7397391f053e54fcf4e19d49304b9e204a5b9fdef0c8732",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2256862219/image_2256862219.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "The 4-factor approach has averaged 18.76% total return, outperforming SCHD's 13.70% over completed 12-month cycles. Read more here.",
                "category": "company",
                "datetime": 1791274326,
                "headline": "SCHD-Inspired 4-Factor Dividend Growth Strategy Selections For October 2026"
              },
              {
                "id": 142663812,
                "url": "https://finnhub.io/api/news?id=f1452b176c313c5241c1ec7c0a16c68a8296a70367f45b8d0a728d6276e2fd4c",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/movers_3.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ZTS",
                "summary": "On Thursday, Zoetis (NYSE:ZTS) discussed second-quarter financial results during its earnings call. The full transcript is provided below.\nThis transcript is brought to you by Benzinga APIs. For real-time access to our",
                "category": "company",
                "datetime": 1791269589,
                "headline": "Zoetis Reports Q2 2026 Results: Full Earnings Call Transcript"
              },
              {
                "id": 142571093,
                "url": "https://finnhub.io/api/news?id=37fe2ca1458d132e96a1ae9e443a3c633aa18af06559c6574ea35036977f4c99",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Zoetis Inc. (NYSE:ZTS) has built one of the strongest franchises in animal health. Its products are used by veterinarians around the world; its portfolio spans medicines, vaccines, and diagnostics, and its research capabilities have helped establish entire categories of treatment. But a moat is only valuable if it protects market share and pricing power when […]",
                "category": "company",
                "datetime": 1790909374,
                "headline": "Zoetis (ZTS) Has a Huge Animal Health Moat. Is It Starting to Crack?"
              },
              {
                "id": 142563955,
                "url": "https://finnhub.io/api/news?id=c980375e3b22071e3c11bec8d34ee762bf7e8770c79fed0b9bdd473835696a72",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZTS",
                "summary": "Zoetis (ZTS) reached $69.1 at the closing of the latest trading day, reflecting a -1.05% change compared to its last close.",
                "category": "company",
                "datetime": 1790889305,
                "headline": "Zoetis (ZTS) Stock Sinks As Market Gains: Here's Why"
              },
              {
                "id": 142559047,
                "url": "https://finnhub.io/api/news?id=37374ce9835e5c61e1fb08021bd85eeb42e992b8d15da14974361471f98b125b",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2209914068/image_2209914068.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "October 2026 Top 25 High-Growth Dividend Stocks trading 31% below intrinsic value, with a projected 22.53% annual return. Read full analysis here.",
                "category": "company",
                "datetime": 1790851234,
                "headline": "Top 25 High-Growth Dividend Stocks For October 2026"
              },
              {
                "id": 142558297,
                "url": "https://finnhub.io/api/news?id=a18bb0839f70d1043459f9e146edff1a12e0e68b0821cfd57c078e1f3dd2e383",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2253044633/image_2253044633.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "The Top 25 stocks average a 3.38% dividend yield and appear ~31% undervalued by dividend yield theory. Read more on the list here.",
                "category": "company",
                "datetime": 1790848800,
                "headline": "Top 25 Attractive Dividend Stocks For October 2026"
              },
              {
                "id": 142512774,
                "url": "https://finnhub.io/api/news?id=a20db31969ad1df3967ae7ef539bdbdd5eb5f43bae7906b15b0adc5bc5eab093",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2233435423/image_2233435423.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZTS",
                "summary": "Zoetis (ZTS) stock: why shares fell 71% and what’s next. Margin strength, pipeline vs. 2030+ patent risks, and $113 fair value.",
                "category": "company",
                "datetime": 1790749881,
                "headline": "Zoetis: Priced For The Worst, Worth Buying"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 3,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.9,
            "source_article_count": 44,
            "discarded_article_count": 30
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 20.8,
        "grade": "一般",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 1.5,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1.5,
            "vcp_reason": "跌縮量(近10日3日)；站上MA50；升放量(近10日3日)；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 6,
              "vol_ref": 4264570,
              "down_days": 3,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 3966270,
              "avg_vol_20": 4121820,
              "avg_vol_30": 4264570,
              "range_pct_10": 0.10028405582314444,
              "range_pct_20": 0.16697542299617155,
              "range_pct_30": 0.16697542299617155,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": true,
              "up_expand_days": 3,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.9300515644015692,
              "dist_to_20d_high": 0.016040831206708073,
              "down_shrink_days": 3,
              "breakout_level_20d": 82.29,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.6005917159763313
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 1.6,
          "volumeWeight": 2,
          "maCrossPoints": 2.4,
          "shortRsiPoints": 1,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 0.4
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.4,
            "details": {
              "atrPct": 2.25132765221687,
              "turnoverUsdM": 235.12190055,
              "liquidityPoints": 0.4,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.ZTS",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 77.3242,
            "strength_details": {
              "ma_score": 2,
              "atr_score": 2,
              "rsi_score": 0.5,
              "macd_score": 3,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.1,
            "stop_loss_percent": 4.5,
            "take_profit_price": 85.0185,
            "target_multiplier": 1.9,
            "technical_strength": 1.75,
            "take_profit_percent": 5
          },
          "positionPoints": 1.4,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 4.50265530443374,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 78.57,
    "atr": {
      "atr": 1.8229,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.25
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "強勢區",
      "score": 10,
      "value": 98.15
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "輕微流入",
      "score": 6,
      "value": 0.1788
    },
    "kdj": {
      "d": 88.33,
      "j": 85.27,
      "k": 87.31,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "強資金流入",
      "score": 10,
      "value": 72.16
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 8,
      "trend": "資金入貨",
      "value": 885285,
      "recentSlope": 1757558.5,
      "previousSlope": 968430
    },
    "rsi": 81.63,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 78.5091,
      "position": "SAR喺價下",
      "distancePct": 3.04,
      "previousTrend": "上升"
    },
    "ma50": 74.7296,
    "macd": {
      "macd": 2.1894809296496476,
      "trend": "強烈看漲",
      "signal": 1.4049133310024091,
      "histogram": 0.7845675986472385
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 74.9607,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 13
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "空升",
      "ratio": 0.71,
      "score": 2,
      "avgVolume": 4071641,
      "currentVolume": 2903815
    },
    "derived": {
      "ma20": 75.3695,
      "ma50": 74.7296,
      "prevClose": 81.03,
      "avgVolume10": 3847702,
      "avgVolume20": 4071641,
      "changePercent": -0.07,
      "avgVolumeForScore": 4071641
    },
    "ma_cross": {
      "ma20": 75.3695,
      "ma50": 74.7296,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "接近",
      "score": 6,
      "prevMa20": 74.8925,
      "prevMa50": 74.586,
      "spreadPct": 0.86,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 66.7466,
      "upper": 83.9924,
      "position": "上半部"
    },
    "rsi_short": 67.71,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.71
    }
  }
}

{
  "close": 80.97,
  "volume": 2903815,
  "changePercent": -0.07
}